CIK 0001737953
- Non-accelerated filer
- Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822082553
- Phone
- +1 781-222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $521,860
- in 2 filings
Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-01 | Slootweg Hugo Alexander Director | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | ||
| 2021-04-01 | SLATTERY JOSEPH P Director | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | ||
| 2021-04-01 | Dhingra Kapil Director | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | ||
| 2021-04-01 | Omega Fund IV, L.P. Director | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | ||
| 2021-03-15 | Love Colin Chief Operating Officer | Sale | −11,382 | $34.06 | $388K | 905,142 |
| 2021-03-15 | Love Colin Chief Operating Officer | Sale | −18,518 | $33.22 | $615K | 886,624 |
| 2021-03-15 | Love Colin Chief Operating Officer | Sale | −100 | $32.67 | $3K | 886,524 |
| 2021-02-16 | Love Colin Chief Operating Officer | Sale | −18,620 | $36.61 | $682K | 927,904 |
| 2021-02-16 | Love Colin Chief Operating Officer | Sale | −11,380 | $35.84 | $408K | 916,524 |
| 2021-02-08 | Omega Fund IV, L.P. 10% owner | Sale | −5,249 | $45.00 | $236K | 5,141,321 |
| 2021-01-26 | Rhodes Jason P Director | Sale | −5,558 | $46.14 | $256K | 946,000 |
| 2021-01-26 | Omega Fund IV, L.P. Director | Sale | −26,957 | $45.34 | $1.2M | 5,287,075 |
| 2021-01-26 | Omega Fund IV, L.P. Director | Sale | −3,393 | $46.04 | $156K | 5,283,682 |
| 2021-01-22 | Coffin Robert President & Chief R&D Officer | Sale | −30,197 | $44.87 | $1.4M | 1,773,921 |
| 2021-01-22 | Coffin Robert President & Chief R&D Officer | Sale | −29,803 | $43.99 | $1.3M | 1,744,118 |
| 2021-01-22 | Omega Fund IV, L.P. Director | Sale | −8,090 | $45.05 | $364K | 5,317,301 |
| 2021-01-22 | Omega Fund IV, L.P. Director | Sale | −3,269 | $45.03 | $147K | 5,314,032 |
| 2021-01-19 | Esposito Pamela Chief Business Officer | Option exercise | +5,727 | $1.01 | $6K | 181,721 |
| 2021-01-19 | Esposito Pamela Chief Business Officer | Sale | −600 | $43.24 | $26K | 181,121 |
| 2021-01-19 | Esposito Pamela Chief Business Officer | Sale | −5,127 | $42.38 | $217K | 175,994 |
Page 15 of 19 · 365 trades